Skip to main content

Table 3 Quality assessment of included non-randomised controlled trials

From: Efficacy and safety of methylene blue in the treatment of malaria: a systematic review

Methodological item

Score for studiesa

Bountogo et al.

Burkina Faso

(2010) [59]

Meissner et al.

Burkina Faso

(2006) [60]

Alving (1949)

Cited by Baird et al. (2012) [61]

Clearly stated aim

2

2

1

Inclusion of consecutive patients

2

2

1

Prospective collection of data

2

2

0

End points appropriate to the aim of the study

1

2

1

Unbiased assessment of the study end point

2

2

0

Follow-up period appropriate to the aim of the study

2

2

1

Loss to follow-up less than 5%

2

2

0

Prospective calculation of the study size

2

2

0

Adequate control group

1

2

1

Contemporary groups

1

1

1

Baseline equivalence of groups

1

2

0

Adequate statistical analyses

2

2

0

Total score

20

23

6

  1. aThe items are scored 0 (not reported), 1 (reported but inadequate) or 2 (reported and adequate). The global ideal score was 24 for comparative studies